Decreased CHK protein levels are associated with Src activation in colon cancer cells

Oncogene

Volumn 27, Issue 14, 2008, Pages 2027-2034

  Zhu, S ^a   Bjorge, J D ^a   Cheng, H C ^b   Fujita, D J ^a,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Health Sciences Centre Calgary   (Canada)

Author keywords

CHK; Colon cancer; src

Indexed keywords

PROTEIN CHK; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; COLON CANCER; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

CELL LINE, TUMOR; COLONIC NEOPLASMS; DOWN-REGULATION; ENZYME ACTIVATION; HUMANS; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS PP60(C-SRC); SRC-FAMILY KINASES;

EID: 41149126804     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210838     Document Type: Article

References (41)

1. Avraham S, Jiang S, Ota S, Fu Y, Deng B, Dowler LL et al. (1995). Structural and functional studies of the intracellular tyrosine kinase MATK gene and its translated product. J Biol Chem 270: 1833-1842.
2. Bennett BD, Cowley S, Jiang S, London R, Deng B, Grabarek J et al. (1994). Identification and characterization of a novel tyrosine kinase from megakaryocytes. J Biol Chem 269: 1068-1074.
3. Bjorge JD, Jakymiw A, Fujita DJ. (2000). Selected glimpses into the activation and function of Src kinase. Oncogene 19: 5620-5635.
4. Bougeret C, Jiang S, Keydar I, Avraham H. (2001). Functional analysis of Csk and CHK kinases in breast cancer cells. J Biol Chem 276: 33711-33720.
5. Cam WR, Masaki T, Shiratori Y, Kato N, Ikenoue T, Okamoto M et al. (2001). Reduced C-terminal Src kinase activity is correlated inversely with pp60(c-src) activity in colorectal carcinoma. Cancer 92: 61-70.
6. Chong YP, Chan AS, Chan KC, Williamson NA, Lerner EC, Smithgall TE et al. (2006). C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases. J Biol Chem 281: 32988-32999.
7. Chong YP, Mulhern TD, Zhu HJ, Fujita DJ, Bjorge JD, Tantiongco JP et al. (2004). A novel non-catalytic mechanism employed by the C-terminal Src-homologous kinase to inhibit Src-family kinase activity. J Biol Chem 279: 20752-20766.
8. Chow LM, Davidson D, Fournel M, Gosselin P, Lemieux S, Lyu MS et al. (1994a). Two distinct protein isoforms are encoded by ntk, a csk-related tyrosine protein kinase gene. Oncogene 9: 3437-3448.
9. Chow LM, Jarvis C, Hu Q, Nye SH, Gervais FG, Veillette A et al. (1994b). Ntk: a Csk-related protein-tyrosine kinase expressed in brain and T lymphocytes. Proc Natl Acad Sci USA 91: 4975-4979.
10. Davidson D, Chow LM, Veillette A. (1997). Chk, a Csk family tyrosine protein kinase, exhibits Csk-like activity in fibroblasts, but not in an antigen-specific T-cell line. J Biol Chem 272: 1355-1362.
11. Ershler MA, Samokhvalov IM, Belyavsky AV, Visser JW. (1995). Genomic structure and alternative splicing of the murine bhk/ctk/ntk gene. FEBS Lett 375: 50-52.
12. Fearon ER, Vogelstein B. (1990). A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
13. Fincham VJ, Brunton VG, Frame MC. (2000). The SH3 domain directs acto-myosin-dependent targeting of v-Src to focal adhesions via phosphatidylinositol 3-kinase. Mol Cell Biol 20: 6518-6536.
14. Fincham VJ, Frame MC. (1998). The catalytic activity of Src is dispensable for translocation to focal adhesions but controls the turnover of these structures during cell motility. EMBO J 17: 81-92.
15. Hirao A, Hamaguchi I, Suda T, Yamaguchi N. (1997). Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated platelets. EMBO J 16: 2342-2351.
16. Hirao A, Huang XL, Suda T, Yamaguchi N. (1998). Overexpression of C-terminal Src kinase homologous kinase suppresses activation of Lyn tyrosine kinase required for VLA5-mediated Dami cell spreading. J Biol Chem 273: 10004-10010.
17. Hunter T. (1987). A tail of two src's: mutatis mutandis. Cell 49: 1-4.
18. Ilyas M, Straub J, Tomlinson IP, Bodmer WF. (1999). Genetic pathways in colorectal and other cancers. Eur J Cancer 35: 1986-2002.
19. Irby RB, Mao W, Coppola D, Kang J, Loubeau JM, Trudeau W et al. (1999). Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet 21: 187-190.
20. Irby RB, Yeatman TJ. (2000). Role of Src expression and activation in human cancer. Oncogene 19: 5636-5642.
21. Isozumi T, Yamada E, Hazama F, Handa J. (1997). Altered expression of src tyrosine kinase after axotomy. Acta Neuropathol (Berl) 93: 438-442.
22. Jove R, Hanafusa H. (1987). Cell transformation by the viral src oncogene. Annu Rev Cell Biol 3: 31-56.
23. Kim S, Zagozdzon R, Meisler A, Baleja JD, Fu Y, Avraham S et al. (2002). Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancer. J Biol Chem 277: 36465-36470.
24. Kim SO, Avraham S, Jiang S, Zagozdzon R, Fu Y, Avraham HK. (2004). Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors. Cancer 101: 1018-1027.
25. Kinzler KW, Vogelstein B. (1996). Lessons from hereditary colorectal cancer. Cell 87: 159-170.
26. Klages S, Adam D, Class K, Fargnoli J, Bolen JB, Penhallow RC. (1994). Ctk: a protein-tyrosine kinase related to Csk that defines an enzyme family. Proc Natl Acad Sci USA 91: 2597-2601.
27. Krueger JG, Wang E, Garber EA, Goldberg AR. (1980). Differences in intracellular location of pp60src in rat and chicken cells transformed by Rous sarcoma virus. Proc Natl Acad Sci USA 77: 4142-4146.
28. Kuismanen SA, Holmberg MT, Salovaara R, de la Chapelle A, Peltomaki P. (2000). Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am J Pathol 156: 1773-1779.
29. Kuo SS, Moran P, Gripp J, Armanini M, Phillips HS, Goddard A et al. (1994). Identification and characterization of Batk, a predominantly brain-specific non-receptor protein tyrosine kinase related to Csk. J Neurosci Res 38: 705-715.
30. Levin VA. (2004). Basis and importance of Src as a target in cancer. Cancer Treat Res 119: 89-119.
31. Nakayama Y, Yamaguchi N. (2005). Multi-lobulation of the nucleus in prolonged S phase by nuclear expression of chk tyrosine kinase. Exp Cell Res 304: 570-581.
32. Sakano S, Iwama A, Inazawa J, Ariyama T, Ohno M, Suda T. (1994). Molecular cloning of a novel non-receptor tyrosine kinase, HYL (hematopoietic consensus tyrosine-lacking kinase). Oncogene 9: 1155-1161.
33. Samokhvalov I, Hendrikx J, Visser J, Belyavsky A, Sotiropolous D, Gu H. (1997). Mice lacking a functional chk gene have no apparent defects in the hematopoietic system. Biochem Mol Biol Int 43: 115-122.
34. Sandilands E, Cans C, Fincham VJ, Brunton VG, Mellor H, Prendergast GC et al. (2004). RhoB and actin polymerization coordinate Src activation with endosome-mediated delivery to the membrane. Dev Cell 7: 855-869.
35. Smith G, Carey FA, Beattie J, Wilkie MJ, Lightfoot TJ, Coxhead J et al. (2002). Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci USA 99: 9433-9438.
36. Staley CA, Parikh NU, Gallick GE. (1997). Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src. Cell Growth Differ 8: 269-274.
37. Trubert CL, Bernard F, Hivroz C, Carlioz A, Fischer A, Cournot G. (1997). PP60c-src expression in osteoclasts from osteopetrotic children and in giant tumor cells. Eur J Histochem 41: 169-176.
38. Watanabe N, Matsuda S, Kuramochi S, Tsuzuku J, Yamamoto T, Endo K. (1995). Expression of C-terminal src kinase in human colorectal cancer cell lines. Jpn J Clin Oncol 25: 5-9.
39. Yamaguchi N, Nakayama Y, Urakami T, Suzuki S, Nakamura T, Suda T et al. (2001). Overexpression of the Csk homologous kinase (Chk tyrosine kinase) induces multinucleation: a possible role for chromosome-associated Chk in chromosome dynamics. J Cell Sci 114: 1631-1641.
40. Zhu S, Bjorge JD, Fujita DJ. (2007). PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation. Cancer Res 67 (in press).
41. Zrihan-Licht S, Lim J, Keydar I, Sliwkowski MX, Groopman JE, Avraham H. (1997). Association of csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cells. J Biol Chem 272: 1856-1863.